Decheng Capital Management Iii (Cayman), LLC Equillium, Inc. Call Options Transaction History
Decheng Capital Management Iii (Cayman), LLC
- $181 Million
- Q3 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EQ
# of Institutions
30Shares Held
11.5MCall Options Held
0Put Options Held
0-
Decheng Capital LLC Menlo Park, CA4.45MShares$4.14 Million0.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA824KShares$766,4040.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$522,918100.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny274KShares$254,9130.0% of portfolio
-
Geode Capital Management, LLC Boston, MA196KShares$182,3640.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $31.9M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...